About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(IgkHyHEL10)1Rbr
transgene insertion 1, Robert Brink
MGI:3800384
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
involves: C57BL/6 MGI:3800464
cx2
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
Tg(ML5sHEL)5Ccg/0
involves: C57BL/6 * C57BL/6JSfd MGI:3800476
cx3
Gpr183tm1.2Rbr/Gpr183tm1.2Rbr
Ightm1Rbr/Ightm1Rbr
Tg(IgkHyHEL10)1Rbr/0
involves: C57BL/6 * FVB/N * SJL MGI:4355855
tg4
Tg(IgkHyHEL10)1Rbr/0 involves: C57BL/6 MGI:3800463


Genotype
MGI:3800464
cx1
Allelic
Composition
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ightm1Rbr mutation (4 available); any Igh mutation (44 available)
Tg(IgkHyHEL10)1Rbr mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• 40-60% of B cells in the spleen produce immunoglobulins that bind hen egg lysozyme antigen (HEL) with high affinity
• the splenic B cells that bind HEL antigen are immature as indicated by the IgMhi IgDhi surface markers
• all of the B cells found in the peritoneal cavity that bind HEL antigen are of the B-2 lineage as determined by B220hi CD5lowexpression
• there are low levels of anti-HEL IgA in the sera of unimmunized mice
• there are low levels of anti-HEL IgG1 in the sera of unimmunized mice
• there are low levels of anti-HEL IgG2a in the sera of unimmunized mice
• there are low levels of anti-HEL IgG2b in the sera of unimmunized mice
• there are low levels of anti-HEL IgG3 in the sera of unimmunized mice
• there are high levels of anti-HEL IgM in the sera of unimmunized mice

immune system
• 40-60% of B cells in the spleen produce immunoglobulins that bind hen egg lysozyme antigen (HEL) with high affinity
• the splenic B cells that bind HEL antigen are immature as indicated by the IgMhi IgDhi surface markers
• all of the B cells found in the peritoneal cavity that bind HEL antigen are of the B-2 lineage as determined by B220hi CD5lowexpression
• there are low levels of anti-HEL IgA in the sera of unimmunized mice
• there are low levels of anti-HEL IgG1 in the sera of unimmunized mice
• there are low levels of anti-HEL IgG2a in the sera of unimmunized mice
• there are low levels of anti-HEL IgG2b in the sera of unimmunized mice
• there are low levels of anti-HEL IgG3 in the sera of unimmunized mice
• there are high levels of anti-HEL IgM in the sera of unimmunized mice




Genotype
MGI:3800476
cx2
Allelic
Composition
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
Tg(ML5sHEL)5Ccg/0
Genetic
Background
involves: C57BL/6 * C57BL/6JSfd
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ightm1Rbr mutation (4 available); any Igh mutation (44 available)
Tg(IgkHyHEL10)1Rbr mutation (4 available)
Tg(ML5sHEL)5Ccg mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• there is a 2-fold reduction in the number of HEL-specific B cells found in the spleen
• HEL-specific B cells in the spleen have mostly have an immature phenotype
• few HEL-specific B cells in the spleen are found in the follicular region or have surface markers indicative of follicular B cells
• very few HEL-specific B cells in the spleen are found in the marginal zone or have surface markers indicative of the marginal zone phenotype

immune system
• there is a 2-fold reduction in the number of HEL-specific B cells found in the spleen
• HEL-specific B cells in the spleen have mostly have an immature phenotype
• few HEL-specific B cells in the spleen are found in the follicular region or have surface markers indicative of follicular B cells
• very few HEL-specific B cells in the spleen are found in the marginal zone or have surface markers indicative of the marginal zone phenotype
• B cells are anergic when stimulated with HEL antigen as determined by reduced antibody production, no upregulation of activation markers CD69 and CD86, and failure to increase size
• these anergic B cells have a short half-life of less than three days
• however, these anergic B cells can proliferate in response to BCR-independent activation




Genotype
MGI:4355855
cx3
Allelic
Composition
Gpr183tm1.2Rbr/Gpr183tm1.2Rbr
Ightm1Rbr/Ightm1Rbr
Tg(IgkHyHEL10)1Rbr/0
Genetic
Background
involves: C57BL/6 * FVB/N * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gpr183tm1.2Rbr mutation (0 available); any Gpr183 mutation (25 available)
Ightm1Rbr mutation (4 available); any Igh mutation (44 available)
Tg(IgkHyHEL10)1Rbr mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• 5 days following immunization with sheep red blood cell, B cells are observed at reduced frequency in the spleen compared to in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• after activation with HEL-conjugated sheep red blood cell, fewer B cells acquired plasmablasts phenotype compared to in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• B cells fail to display a robust extrafollicular plasmablast response due to reduced migration of responding B cells to the bridging channel and red pulp arrears unlike in Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• however, expression of chemokine receptors is normal
• 1 day after activation with HEL-conjugated sheep red blood cell, B cells do not distribute uniformly along the B-T boundary in the spleen and often migrate deep into T cell areas unlike in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• 3 days after activation with HEL-conjugated sheep red blood cell, B cells fail to move to the poles of the B cell follicles proximal to bridging and interfollicular regions and instead remain localized in central follicular areas proximal to the T cell zone unlike in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• following immunization with sheep red blood cell, B cell proliferation is delayed compared to in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• following activation with HEL-conjugated sheep red blood cell, anti-HEL IgG1 levels are reduced to 10% to 20% of that in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• following activation with HEL-conjugated sheep red blood cell, anti-HEL IgM levels are reduced to 10% to 20% of that in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice

hematopoietic system
• 5 days following immunization with sheep red blood cell, B cells are observed at reduced frequency in the spleen compared to in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• after activation with HEL-conjugated sheep red blood cell, fewer B cells acquired plasmablasts phenotype compared to in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• B cells fail to display a robust extrafollicular plasmablast response due to reduced migration of responding B cells to the bridging channel and red pulp arrears unlike in Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• however, expression of chemokine receptors is normal
• 1 day after activation with HEL-conjugated sheep red blood cell, B cells do not distribute uniformly along the B-T boundary in the spleen and often migrate deep into T cell areas unlike in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• 3 days after activation with HEL-conjugated sheep red blood cell, B cells fail to move to the poles of the B cell follicles proximal to bridging and interfollicular regions and instead remain localized in central follicular areas proximal to the T cell zone unlike in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• following immunization with sheep red blood cell, B cell proliferation is delayed compared to in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• following activation with HEL-conjugated sheep red blood cell, anti-HEL IgG1 levels are reduced to 10% to 20% of that in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• following activation with HEL-conjugated sheep red blood cell, anti-HEL IgM levels are reduced to 10% to 20% of that in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice

cellular
• 1 day after activation with HEL-conjugated sheep red blood cell, B cells do not distribute uniformly along the B-T boundary in the spleen and often migrate deep into T cell areas unlike in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• 3 days after activation with HEL-conjugated sheep red blood cell, B cells fail to move to the poles of the B cell follicles proximal to bridging and interfollicular regions and instead remain localized in central follicular areas proximal to the T cell zone unlike in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice
• following immunization with sheep red blood cell, B cell proliferation is delayed compared to in similarly treated Ightm1Rbr/Ightm1Rbr Tg(IgkHyHEL10)1Rbr mice




Genotype
MGI:3800463
tg4
Allelic
Composition
Tg(IgkHyHEL10)1Rbr/0
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(IgkHyHEL10)1Rbr mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory